Strategies to improve ingestive behaviour with reference to critical illness

Proceedings of the Nutrition Society

Volumn 66, Issue 3, 2007, Pages 346-350

  Davidson, Isobel ^a   Smith, Sara ^a  

^a QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Critical illness; Ghrelin; Ingestion behaviour; Intervention strategies

Indexed keywords

CANNABINOID RECEPTOR AGONIST; GHRELIN; SEROTONIN; THALIDOMIDE;

ANOREXIA; BRAIN REGION; CATABOLISM; CRITICAL ILLNESS; ENTERIC FEEDING; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HYPOTHALAMUS; INFLAMMATION; INGESTION; MOTIVATION; NEUROTRANSMISSION; NUTRITIONAL STATUS; PHYSICAL CAPACITY; REVIEW; SATIETY;

APPETITE; CRITICAL ILLNESS; ENERGY INTAKE; HUMANS; PEPTIDE HORMONES; SATIATION;

EID: 34447512945     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665107005605     Document Type: Review

References (36)

1. Adrian TE (2005) Importance of gut peptides in gastrointestinal, metabolic and malignant disease. Current Opinion in Endocrinology and Diabetes 12, 80-88.
2. Akamizu A & Kengawa K (2007) Emerging results of anti-catabolic therapy with ghrelin. Current Opinion in Clinical Nutrition and Metabolic Care 10, 278-283.
3. Bannerman E, Davidson HIM, Aldhous M & Ghosh S (2001) Altered subjective appetite parameters in Crohns disease patients. Clinical Nutrition 20, 399-405.
4. Barber MD, Ross JA & Fearon KCH (1998) An eicosapentaenoic acid-enriched nutritional supplement reverses cachexia in patients with advanced pancreatic cancer. British Journal of Surgery 85, Suppl. 1, 46.
5. Baynes KCR, Dhillo WS & Bloom SR (2006) Regulation of food intake by gastrointestinal hormones. Current Opinion in Gastroenterology 22, 626-631.
6. Berenstein EG & Ortiz Z (2006) Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Pain, Palliative and Supportive Care Group. The Cochrane Database of Systematic Reviews, issue 4. Chichester, West Sussex: John Wiley and Sons Ltd.
7. Blundell J & Tremblay A (1995) Appetite control and energy (fuel) balance. Nutrition Research Reviews 8, 225-242.
8. Boyes SA, Stratton RJ, Jackson JM, Shearman CP & Elia M (2006) Postoperative ghrelin concentrations and the acute phase response after major elective vascular surgery. British Journal of Surgery 93, Suppl. 1, 96.
9. Bruera E, Strasser F, Palmer LJ, Willey J, Calder K, Amyotte G & Baracos V (2003) Effect of fish oil on appetite and other parameters in patients with advanced cancer and anorexia/cancer: a double blind placebo controlled study. Journal of Clinical Oncology 21, 129-134.
10. Congalves CG, Ramos EC, Romanova IC, Suzuki S, Chen C & Meguid MM (2006) Omega-3 fatty acids improve appetite in cancer but tumor resecting restores it. Surgery 139, 202-208.
11. Edelman MJ, Gandara DR & Myers FJ (1999) Serotonergic blockade in the treatment of cancer-cachexia anorexia. Cancer 86, 684-688.
12. Eneroth M, Ollson U-B & Thorngrem K-G (2006) Nutritional supplementation decreases hip fracture related complications. Clinical Orthopaedics and Related Research 451, 212-217.
13. Fearon K, Barber M, Moses A, Ahmedzai S, Taylor G, Tisdale M & Murray G (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. Journal of Clinical Oncology 24, 3401-3407.
14. Febbraio MA & Pedersen BK (2002) Muscle derived IL-6: mechanisms for activation and possible biological roles. FASEB Journal 16, 1335-1347.
15. Harvey RF & Bradshaw JM (1980) A simple index of Crohn's-disease activity. Lancet i, 514.
16. Hill GL (1996) Implications of critical illness, injury and sepsis on lean body mass and nutritional needs. Nutrition 16, 197-218.
17. Jonsson K-O, Holt S & Fowler CJ (2006) The endocannabinoid system: current pharmacological research and therapeutic possibilities. Basic Clinical Pharmacology and Toxicology 28, 124-134.
18. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
19. Kirschgessner AL (2002) Orexins in the brain-gut axis. Endocrine Reviews 23, 1-15.
20. McCollum K (2000) Appetite and nutritional intake in patients with chronic liver disease. Journal of Human Nutrition and Dietetics 13, 363-371.
21. Mantovani G, Maccio A, Massa E & Maddedu C (2001) Managing cancer related anorexia/cachexia. Drugs 61, 499-514.
22. Mayer EA, Tillisch K & Bradesi S (2006) Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Alimentary Pharmacology and Therapeutics 24, 919-933.
23. Milani RV, Lavie CJ & Mehra MR (2004) Reduction in C-reactive protein through cardiac rehabilitation and exercise training. Journal of the American College of Cardiology 43, 1056-1061.
24. Morton GJ, Cummings DE, Baskin DG, Barsh GS & Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443, 289-295.
25. Murray CD, Roux CW, Goueia C, Bassett P, Ghatei MA, Bloom SR, Emmanuel AV & Gabe SM (2006) The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients. Clinical Nutrition 25, 626-633.
26. Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, Miyatake K & Kangawa K (2005) Treatment of cachexia with ghrelin in patients with COPD. Chest 128, 1187-1193.
27. Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei, MA, Coombes RC & Bloom SR (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute randomized placebo controlled trial. Journal of Clinical Endocrinology and Metabolism 89, 2832-2836.
28. Pedersen BK & Saltin B (2006) Evidence for prescribing exercise as therapy in chronic disease. Scandinavian Journal of Medicine and Science in Sports 16, Suppl. 1, 3-63.
29. Reid C (2005) Frequency of under and over feeding in mechanically ventilated ICU patients: possible causes and consequences. Journal of Human Nutrition and Dietetics 19, 13-22.
30. Richardson RA & Davidson HIM (2002) Nutritional demands in acute and chronic illness. Proceedings of the Nutrition Society 62, 777-781.
31. Smith S, Greig CA, Jenkins DAS & Davidson I (2006) Improvements in functional and clinical parameters following a simple 12 month exercise programme in long term haemo-dialysis patients. Nephrology Dialysis Transplantation 21, Suppl. 4, 472-473.
32. Stenvinkel P (2006) Inflammation in end stage renal disease: the hidden enemy. Nephrology 11, 36-41.
33. Stratton R & Elia M (1999) The effects of enteral tube feeding and parenteral nutrition on appetite sensations and food intake in health and disease. Clinical Nutrition 18, 63-70.
34. Stratton R, Stubbs J & Elia M (1998) Appetite and food intake during enteral nutrition. Proceedings of the Nutrition Society 57, 96A.
35. van den Berghe G, Wouters P, Bouillon R, Weekers F, Verwaest C, Schetz C, Viasselaers D, Ferdinande P & Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycaemic control. Critical Care Medicine 31, 359-366.
36. Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, Ghatei MA, Brown EA, Bloom SR & Choi P (2005) Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive peritoneal dialysis: a randomized placebo controlled trial. Journal of the American Society of Nephrology 16, 2111-2118.